Status:
UNKNOWN
Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Collaborating Sponsors:
Universidad Católica San Antonio de Murcia
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Using a smart device (Beprevent) to monitor activities of daily living improves the lifestyle of patients with DM2
Detailed Description
A 6-month randomized clinical trial to evaluate a home activity control system (Beprevent) in the management of the patient with DM2, through the individualized labeling of objects related to them. Th...
Eligibility Criteria
Inclusion
- ≥ 18 years, with the ability to give informed consent
- Patient who has autonomy to carry out activities of daily living (Barthel = 100)
- patient diagnosed with Diabetes Mellitus
- patient in pharmacological treatment
- To live alone or with a person who cannot move on their own
- they do not plan to change their address in the 6 months after inclusion in the study
Exclusion
- • DM2 patients whose most recent HbA1c value is ≤7%
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04380844
Start Date
February 1 2021
End Date
November 1 2021
Last Update
December 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.